Susquehanna International Group, LLP Nuvectis Pharma, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 45,274 shares of NVCT stock, worth $280,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,274
Previous 76,400
40.74%
Holding current value
$280,698
Previous $746,000
54.69%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVCT
# of Institutions
50Shares Held
3.2MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.13 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.49 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.31 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.17 Million0.15% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.77 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $90.8M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...